Tracking tumors inside the body may become easier with the help of a newly developed “in-body GPS” called Remix, developed by researchers at the Massachusetts Institute of Technology (MIT)’s Computer Science and Artificial Intelligence Laboratory (CSAIL) in collaboration with Massachusetts General Hospital.

Researchers at Oregon Health and Science University are using MRI to map patients’ “functional fingerprints,” or the connectomes that make their brains unique, Wired reported this week.

Veterans who utilize Medicare and other fee-for-service health systems for prostate cancer care are more likely to receive guideline-discordant imaging than those treated at the Veterans Health Administration (VA), according to a study published Aug. 17 in JAMA Network Open.

Facebook and the department of radiology at NYU School of Medicine in New York City have announced a new collaboration that will focus on using artificial intelligence (AI) to make MRI scans up to 10 times faster.

The County Durham and Darlington NHS Foundation Trust in England announced this week it had been spending between £2 million and £2.5 million—up to $3.2 million in U.S. dollars—each year to rent MRI scanning equipment from a private company, according to the Northern Echo.

A new clinical trial—brain xxygen optimization in severe traumatic brain injury, Phase 3 (BOOST-3)—will build off prior research with a goal of improving outcomes in those victims of severe TBI, according to a University of Michigan release.

Researchers studying MRI images of the functional connections in the brain have found that an individual's “functional fingerprint” may be used to distinguish individuals over the course of their lifetime, according to an article published Aug. 16 by Quanta Magazine.

Aetna announced, Thursday, Aug. 16, it will expand its coverage of the PET tracer gallium-68 (Ga-68) dotatate, according to a Society of Nuclear Medicine and Molecular Imaging (SNMMI) release. The radiopharmaceutical is now considered “medically necessary.”